These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30067934)

  • 1. Gaining on Pain.
    Emery EC; Wood JN
    N Engl J Med; 2018 Aug; 379(5):485-487. PubMed ID: 30067934
    [No Abstract]   [Full Text] [Related]  

  • 2. Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain.
    Stockstill K; Doyle TM; Yan X; Chen Z; Janes K; Little JW; Braden K; Lauro F; Giancotti LA; Harada CM; Yadav R; Xiao WH; Lionberger JM; Neumann WL; Bennett GJ; Weng HR; Spiegel S; Salvemini D
    J Exp Med; 2018 May; 215(5):1301-1313. PubMed ID: 29703731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexually dimorphic therapeutic response in bortezomib-induced neuropathic pain reveals altered pain physiology in female rodents.
    Stockstill K; Wahlman C; Braden K; Chen Z; Yosten GL; Tosh DK; Jacobson KA; Doyle TM; Samson WK; Salvemini D
    Pain; 2020 Jan; 161(1):177-184. PubMed ID: 31490328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn.
    Doolen S; Iannitti T; Donahue RR; Shaw BC; Grachen CM; Taylor BK
    Pain; 2018 Feb; 159(2):224-238. PubMed ID: 29140922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers.
    Cartwright TA; Campos CR; Cannon RE; Miller DS
    J Cereb Blood Flow Metab; 2013 Mar; 33(3):381-8. PubMed ID: 23168528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on sphingosine-1-phosphate receptor 1 modulators.
    Marciniak A; Camp SM; Garcia JGN; Polt R
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3585-3591. PubMed ID: 30409535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1.
    Janes K; Little JW; Li C; Bryant L; Chen C; Chen Z; Kamocki K; Doyle T; Snider A; Esposito E; Cuzzocrea S; Bieberich E; Obeid L; Petrache I; Nicol G; Neumann WL; Salvemini D
    J Biol Chem; 2014 Jul; 289(30):21082-97. PubMed ID: 24876379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling.
    Mike EV; Makinde HM; Der E; Stock A; Gulinello M; Gadhvi GT; Winter DR; Cuda CM; Putterman C
    Front Immunol; 2018; 9():2189. PubMed ID: 30319641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA3-dependent epigenetic upregulation of CCL21 is involved in the development of neuropathic pain induced by bortezomib.
    Zheng Y; Sun Y; Yang Y; Zhang S; Xu T; Xin W; Wu S; Zhang X
    Mol Pain; 2019; 15():1744806919863292. PubMed ID: 31257992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of sphingosine-1-phosphate receptors on reactive astrocytes drives neuropathology of multiple sclerosis rebound after fingolimod discontinuation.
    Giordana MT; Cavalla P; Uccelli A; Laroni A; Bandini F; Vercellino M; Mancardi G
    Mult Scler; 2018 Jul; 24(8):1133-1137. PubMed ID: 29708466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the sphingolipid signaling pathway in stroke.
    Pfeilschifter W; Czech B; Neumann-Haefelin T
    Stroke; 2010 Apr; 41(4):e193; author reply e194. PubMed ID: 20185772
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic Potential of the Modulation of Sphingosine-1-Phosphate Receptors.
    Delgado A; Martínez-Cartro M
    Curr Med Chem; 2016; 23(3):242-64. PubMed ID: 26639095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
    Spampinato SF; Obermeier B; Cotleur A; Love A; Takeshita Y; Sano Y; Kanda T; Ransohoff RM
    PLoS One; 2015; 10(7):e0133392. PubMed ID: 26197437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine-1-phosphate signaling: A novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain.
    Singh SK; Spiegel S
    Adv Biol Regul; 2020 Jan; 75():100670. PubMed ID: 31708456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.
    Kim S; Bielawski J; Yang H; Kong Y; Zhou B; Li J
    Glia; 2018 Mar; 66(3):654-669. PubMed ID: 29193293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of S1P acting both inside and outside the cells].
    Okada T; Nakamura S
    Seikagaku; 2012 Feb; 84(2):92-101. PubMed ID: 22550899
    [No Abstract]   [Full Text] [Related]  

  • 17. Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation.
    Rothhammer V; Kenison JE; Tjon E; Takenaka MC; de Lima KA; Borucki DM; Chao CC; Wilz A; Blain M; Healy L; Antel J; Quintana FJ
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2012-2017. PubMed ID: 28167760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates on sphingolipids: Spotlight on retinopathy.
    Shiwani HA; Elfaki MY; Memon D; Ali S; Aziz A; Egom EE
    Biomed Pharmacother; 2021 Nov; 143():112197. PubMed ID: 34560541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of P2X7 Receptors Contributes to Spinal Microglial Activation and the Development of Pain Induced by BmK-I.
    Zhou J; Zhang X; Zhou Y; Wu B; Tan ZY
    Neurosci Bull; 2019 Aug; 35(4):624-636. PubMed ID: 30820829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-mediated downregulation of spinal astrocytic connexin43 leads to increased glutamatergic neurotransmission and neuropathic pain in mice.
    Morioka N; Zhang FF; Nakamura Y; Kitamura T; Hisaoka-Nakashima K; Nakata Y
    Brain Behav Immun; 2015 Oct; 49():293-310. PubMed ID: 26116449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.